Mizuho Securities USA’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
6,420
+1,408
+28% +$370K 0.03% 462
2026
Q1
$1.34M Sell
5,012
-1,024
-17% -$277K 0.03% 476
2025
Q4
$1.62M Sell
6,036
-16
-0.3% -$4.25K 0.03% 477
2025
Q3
$1.68M Buy
6,052
+263
+5% +$70.5K 0.03% 465
2025
Q2
$1.52M Sell
5,789
-889
-13% -$216K 0.03% 462
2025
Q1
$1.55M Sell
6,678
-1,249
-16% -$303K 0.03% 447
2024
Q4
$1.82M Buy
7,927
+2,482
+46% +$569K 0.03% 437
2024
Q3
$1.22M Sell
5,445
-1,054
-16% -$232K 0.03% 457
2024
Q2
$1.32M Buy
+6,499
New +$1.32M 0.03% 451

Other funds holding LH

Mizuho Securities USA's LH Position: Q2 2026 in Review

Mizuho Securities USA increased its Labcorp (LH) stake by 28% in Q2 2026, buying an estimated $370K and bringing the position to 6,420 shares worth $1.8M. The position accounts for 0.03% of the portfolio, ranked #462.

Mizuho Securities USA first reported a position in LH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.82M in Q4 2024. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Mizuho Securities USA held 6,420 shares of Labcorp worth $1.8M as of Q2 2026.
  • Mizuho Securities USA bought 1,408 Labcorp shares in Q2 2026, an estimated $370K.
  • Labcorp made up 0.03% of Mizuho Securities USA's portfolio in Q2 2026, its #462 holding.
  • Mizuho Securities USA first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • Mizuho Securities USA's Labcorp position peaked at $1.82M in Q4 2024.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.